Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating obesity employing an SGLT2 inhibitor

Methods for treating obesity employing an SGLT2 inhibitor

US Patent 8088743 · Granted Jan 3, 2012

Estimated economic value: $237,401,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists2017
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists2016
Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators2015
Methods for treating obesity employing an SGLT2 inhibitor2014
Methods for treating obesity employing an SGLT2 inhibitor2014
Methods for treating obesity employing an SGLT2 inhibitor2014
Methods for treating obesity employing an SGLT2 inhibitor2014
Azolotriazinone melanin concentrating hormone receptor-1 antagonists2014
Methods for treating extreme insulin resistance in patients resistant to previou2014
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for usin2013
Azolotriazinone melanin concentrating hormone receptor-1 antagonists2013
Tool suite for RTL-level reconfiguration and repartitioning2013